Monetary Management Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$10K 353
2021
Q4
$10K Sell
100
-20
-17% -$2.07K ﹤0.01% 342
2021
Q3
$15K Hold
120
﹤0.01% 318
2021
Q2
$15K Hold
120
﹤0.01% 302
2021
Q1
$18K Sell
120
-2,930
-96% -$443K 0.01% 291
2020
Q4
$393K Sell
3,050
-2,200
-42% -$253K 0.13% 127
2020
Q3
$587K Sell
5,250
-1,050
-17% -$96.1K 0.21% 94
2020
Q2
$511K Buy
+6,300
New +$508K 0.19% 99
2020
Q1
Sell
-2,250
Closed -$176K 283
2019
Q4
$176K Buy
2,250
+1,000
+80% +$72.1K 0.06% 168
2019
Q3
$80K Buy
+1,250
New +$110K 0.03% 211

Other funds holding GH

Monetary Management Group's GH Position: Q1 2022 in Review

Monetary Management Group sold out of Guardant Health (GH) in Q1 2022, closing a stake of 100 shares — an estimated $10K sold.

Monetary Management Group first reported a position in GH in Q3 2019 and held it in 9 quarters. The position peaked at $587K in Q3 2020. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Monetary Management Group reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Monetary Management Group sold 100 Guardant Health shares in Q1 2022, an estimated $10K.
  • Monetary Management Group first reported a position in Guardant Health in Q3 2019 and held it in 9 quarters.
  • Monetary Management Group's Guardant Health position peaked at $587K in Q3 2020.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Monetary Management Group's 13F filing for Q1 2022, filed 12 May 2022.